Literature DB >> 8995949

Improved localizing method of radiopill in measurement of entire gastrointestinal pH profiles: colonic luminal pH in normal subjects and patients with Crohn's disease.

Y Sasaki1, R Hada, H Nakajima, S Fukuda, A Munakata.   

Abstract

OBJECTIVE: To measure gastrointestinal (GI) pH profiles in patients with Crohn's disease with an improved pH radiotelemetry method.
METHODS: A computer-assisted method was developed to exactly localize a pH sensitive radiotelemetry capsule (radiopill) in the GI tract from the stomach to the cecum by detecting distinct changes in transmitted pH signals sampled at 1-sec intervals. The combined usage of a radiodirectional probe facilitated localization of the radiopill in the colon. With this improved method, GI pH profiles in four patients (male/female, 3/1; age range, 21-34 yr) with Crohn's disease that involved the left colon (active disease: 3; disease at quiescent state, 1) were measured and compared with those in four gender- and age-matched control subjects (controls).
RESULTS: Gastric and small intestinal luminal pH profiles in Crohn's disease were similar to those in the controls. In contrast, colonic luminal pH profiles in both right (uninvolved) and left (involved) colon in active or quiescent Crohn's disease showed more coarse fluctuations with a significantly low value than those seen in the controls. The minimum colonic pH registered in the four patients was 0.6, 1.2, 3.2, and 5.3 pH unit, respectively. The overall mean luminal pH (+/-SD) in the right colon was 5.3 +/- 0.3 for the patients versus 6.8 +/- 0.2 for the controls (p < 0.01) and that in the left colon was 5.3 +/- 0.7 versus 7.2 +/- 0.3 (p < 0.01), respectively.
CONCLUSION: This study first demonstrates that an extremely acidic colonic environment occurs in either active or inactive Crohn's disease.

Entities:  

Mesh:

Year:  1997        PMID: 8995949

Source DB:  PubMed          Journal:  Am J Gastroenterol        ISSN: 0002-9270            Impact factor:   10.864


  22 in total

1.  Inflammation does not decrease intraluminal pH in chronic inflammatory bowel disease.

Authors:  K Ewe; S Schwartz; S Petersen; A G Press
Journal:  Dig Dis Sci       Date:  1999-07       Impact factor: 3.199

2.  Small intestinal transit time and intraluminal pH in ileocecal resected patients with Crohn's disease.

Authors:  J Fallingborg; P Pedersen; B A Jacobsen
Journal:  Dig Dis Sci       Date:  1998-04       Impact factor: 3.199

3.  Low-power wireless electronic capsule for long-term gastrointestinal monitoring.

Authors:  Kai Zhao; Guozheng Yan; Li Lu; Fei Xu
Journal:  J Med Syst       Date:  2015-01-29       Impact factor: 4.460

Review 4.  Intestinal luminal pH in inflammatory bowel disease: possible determinants and implications for therapy with aminosalicylates and other drugs.

Authors:  S G Nugent; D Kumar; D S Rampton; D F Evans
Journal:  Gut       Date:  2001-04       Impact factor: 23.059

Review 5.  A Quantitative Review and Meta-Models of the Variability and Factors Affecting Oral Drug Absorption-Part I: Gastrointestinal pH.

Authors:  Ahmad Y Abuhelwa; David J R Foster; Richard N Upton
Journal:  AAPS J       Date:  2016-08-05       Impact factor: 4.009

6.  Nanoparticulate Drug Delivery Systems Targeting Inflammation for Treatment of Inflammatory Bowel Disease.

Authors:  Sufeng Zhang; Robert Langer; Giovanni Traverso
Journal:  Nano Today       Date:  2017-10-09       Impact factor: 20.722

7.  Gastrointestinal pH profile in subjects with irritable bowel syndrome.

Authors:  David Lalezari
Journal:  Ann Gastroenterol       Date:  2012

Review 8.  The ileal brake: a fifteen-year progress report.

Authors:  G W Van Citters; H C Lin
Journal:  Curr Gastroenterol Rep       Date:  1999-10

9.  GPR4 deficiency alleviates intestinal inflammation in a mouse model of acute experimental colitis.

Authors:  Edward J Sanderlin; Nancy R Leffler; Kvin Lertpiriyapong; Qi Cai; Heng Hong; Vasudevan Bakthavatchalu; James G Fox; Joani Zary Oswald; Calvin R Justus; Elizabeth A Krewson; Dorcas O'Rourke; Li V Yang
Journal:  Biochim Biophys Acta Mol Basis Dis       Date:  2016-12-07       Impact factor: 5.187

10.  Mitigation of colitis with NovaSil clay therapy.

Authors:  Katherine E Zychowski; Sarah E Elmore; Kristal A Rychlik; Hoai J Ly; Felipe Pierezan; Anitha Isaiah; Jan S Suchodolski; Aline Rodrigues Hoffmann; Amelia A Romoser; Timothy D Phillips
Journal:  Dig Dis Sci       Date:  2014-09-21       Impact factor: 3.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.